Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance

Success marked by 18 percent growth in exhibitors and 9 percent in attendees

Saudi Arabia Poised to Expand Domestic Manufacturing Eco-system as 30,000 Attendees join Inaugural CPHI Middle East

Partnering surge predicted as new pharma manufacturing technology investment presents opportunity to leap ahead of legacy markets

CPHI Milan Report: CMOs and hybrid companies will hold 54% of biologics capacity in 2028

CMOs will account for four of the five biggest capacity holders in 2028, with 45% of all CMO capacity in Asia

CPHI Milan Survey ‘faster CDMO growth in 2025 predicted’ and ‘industry not in favour of BIOSECURE Act’

49% of industry is ‘highly positive’ on contract services growth in the next 18-months

Biotech Capital on the Rise and Outsourcing to Accelerate in 2025 - but Uneven Growth for CDMOs

New research launched at CPHI Milan forecasts promising growth for biotech and pharma markets in the coming year, bringing growth opportunities for outsourcing providers.

CPHI Excellence in Pharma Award Winners 2024

Fourteen categories celebrate pharma innovation across supply chain and spotlight leaders driving excellence as CPHI announces the winners of the prestigious 2024 CPHI Pharma Awards

Global Sustainability Collective and Women’s Mentoring Programme announced at CPHI Milan

Recognising its pivotal role in shaping the future of pharma, CPHI Milan is introducing efforts aimed at fostering sustainability and nurturing the next generation of women leaders in the industry.

CPHI Milan analysis ‘Lombardy the best location for pharma manufacturing in Europe’

Report predicts significant growth for Lombardy’s pharma industry in 2025 as event directly contributes more than €120m to region

CPHI Milan Report predicts BLA and Tides approvals will surpass small molecules within the next three years

Bio and Tides predicted to be the fastest growing modality for CDMOs over the next five years

CPHI Milan Announce Pharma Award finalists

Finalists span 14 categories including awards for future leaders, women of the year and ‘at the heart of pharma’

CPHI Korea 2024 opens with 15% growth as innovation booms in Korea

Event’s most international edition sees health ingredients, nutraceuticals and biopharma driving growth

Pharma services boom in China as CPHI & PMEC China posts record attendance

Domestic and international markets in Asia surging as CPHI & PMEC China welcomes a stagging 93,000 attendees

Dive into the Heart of Pharma at CPHI Milan, October 8-10th 2024 – a celebration of pharma

Dive into the Heart of Pharma at CPHI Milan, October 8-10th 2024 – a celebration of pharma

CPHI South East Asia opens as growth prospects outlined for pharmaceutical development in Vietnam, Thailand and Cambodia

CPHI returns to the Messe Frankfurt in 2025

The Heart of Pharma will return to Europe’s leading pharma manufacturing region

CPHI North America expanding Bioproduction focus for 2025

Surge in purchasing executive attendance is clear signal of demand for wider supply chain partner options

Record numbers expected at CPHI & PMEC China 2024 as Asian markets boom

Domestic and international markets in Asia surging as CPHI & PMEC China welcomes 60,000 attendees and 3500 exhibitors

CPHI North America experts ‘mid-sized domestic CDMOs need to invest in operational efficiencies to drive “real” reshoring’

Supply chain resilience and new partner sourcing to benefit from a boom in outsourcing in 2025

Rapid increase in purchasing teams expected at CPHI North America

Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event

CPHI North America opens as 65% of US companies forecast growth in excess of 20% in 2022

CPHI is the leading global community for pharmaceutical professionals and America’s only end-to-end pharma event

Japan tops CPhI ‘API Quality’ ranking for second year

Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers

2022 will see pharma target nutraceutical products to tap into consumer spending on preventative health

2025 forecast: massive growth expected in consumer-friendly dosages using natural ingredients for proactive & pre-emptive health

CPhI predictions for 2022: high manufacturing demand to constrain global ingredients, partnering options and available CDMO capacity

Continued stellar growth in pharma sales and innovation bode well for supply side companies and CDMOs

Medinfar awarded first ever CPhI Verified Certificate

CPhI Verified certification improves supply chain transparency, providing a legal, regulatory and quality benchmark

Global pharma industry gathers at CPhI Worldwide 2021 as surge in partnering expected in 2022

Over 25,000 online and 23,000 in person attendees at the world’s largest pharma trade exhibition

China sees huge bounce in pharma rankings ahead of hybrid CPhI & P-MEC China

China is the pharma industry’s biggest gainer in the 2021 CPhI Annual Rankings, with digital matchmaking driving new waves of partnerships

Pharma confidence surges as CPhI Worldwide 2021 opens

CPhI Pharma Index reaches record high as pharma confidence in growth rises in all markets

Winners of the 2021 CPhI Pharma Awards have now been announced

CPhI Worldwide Report: CMOs will account for four of the five top bio manufacturing capacities in 2025

230 Covid-19 supply agreements known, with demand for larger biocapacity remaining constrained as a consequence of the circa 1000 vaccines in development

India sees sizable improvement in finished dosage reputation and growth ahead of CPhI India 2021

CPhI & P-MEC India delivers hybrid event as country improves across all key performance metrics in CPhI global survey

Short term reshoring the catalyst for longer term manufacturing innovations by 2030